SCHEMBL5259271

SCHEMBL5259271

COc1cccc(C(=O)c2cc(C(=O)NCCOCCOCCN)c3ccc4ccccc4n23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.48
▸ RAB9A P51151 6/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ FNTA P49354 2/20 0.41
▸ FNTB P49356 2/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MCHR1 Q99705 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ NQO2 P16083 1/20 0.38
▸ MTNR1A P48039 1/20 0.38
▸ MTNR1B P49286 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5311112 0.82 HDAC3 (0.48) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL5959274 0.70 CNR2 (0.40) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL30184646 0.69 GAA (0.70) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL29760721 0.68 GAA (0.67) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL21142116 0.67 SMN1; SMN2 (0.66) NPC1RAB9ASMN1; SMN2HSD17B10GAA
SCHEMBL16449002 0.66 GAA (0.77) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL15071686 0.66 GAA (0.69) NPC1RAB9ASMN1; SMN2TP53HTT
SCHEMBL16677166 0.66 NPC1 (0.61) NPC1RAB9ASMN1; SMN2HSD17B10ALDH1A1
SCHEMBL30380731 0.66 GAA (0.72) NPC1RAB9ASMN1; SMN2GAAMAPT
SCHEMBL891480 0.66 ALDH1A1 (0.64) NPC1RAB9ASMN1; SMN2TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578424-A4 SUBSTITUTED 1-BENZOYL-3-CYANO-PYRROLO 1,2-A| QUINOLINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS CYTOVIA INC (US) 2007-08-08 — — EP claimed
EP-1578424-A2 SUBSTITUTED 1-BENZOYL-3-CYANO-PYRROLO 1,2-A] QUINOLINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS Cytovia, Inc. (US) 2005-09-28 — — EP claimed
WO-2004055163-A2 SUBSTITUTED 1-BENZOYL-3-CYANO-PYRROLO[1,2-A]QUINOLINES CYTOVIA, INC. (US) 2004-07-01 — — WO claimed
EP-1578424-A4 SUBSTITUTED 1-BENZOYL-3-CYANO-PYRROLO 1,2-A| QUINOLINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS CYTOVIA INC (US) 2007-08-08 — — EP disclosed
EP-1578424-A2 SUBSTITUTED 1-BENZOYL-3-CYANO-PYRROLO 1,2-A] QUINOLINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS Cytovia, Inc. (US) 2005-09-28 — — EP disclosed
WO-2004055163-A2 SUBSTITUTED 1-BENZOYL-3-CYANO-PYRROLO[1,2-A]QUINOLINES CYTOVIA, INC. (US) 2004-07-01 — — WO disclosed
Send feedback